Gender-specific aspects of alpha-1-antitrypsin deficiency in relation to lung and liver disease, symptom burden and exacerbations: Data from the EARCO registry
Ersöz,H.,Torres-Duran,M.,Turner,A.,Tanash,H.,Rodriguez Garcia,C.,Corsico,A. G.,Lopez-Campos,J. L.,Miravitlles,M.,Clarenbach,C. F.,Chapman,K. R.,Hernandez Perez,J. M.,Guimaraes,C.,Bartosovska,E.,Greulich,T.,Herth,F.,Trudzinski,F. C.,Höger,P.,Olivares Rivera,A.
DOI: https://doi.org/10.1183/13993003.congress-2024.oa4648
IF: 24.3
2024-11-01
European Respiratory Journal
Abstract:Background: Gender affects many aspects of chronic obstructive pulmonary disease (COPD). Limited data are available on gender issues in alpha-1 antitrypsin deficiency (AATD). We investigated gender issues in the EARCO registry, a prospective observational cohort study. Methods: Baseline data from PiZZ individuals, enrolled in the registry with complete data on sex and smoking history were analysed by group comparisons and binary logistic regression analyses. Results: 1283 patients with AATD, 633 females were analysed. Females were older than males (56.7±13.6 vs. 54.3±14.2y p=0.002), reported less tobacco consumption (16.8±12.2 vs. 19.6±14.5 PY p=0.006) and consumed less alcohol (5.5±7.6 vs. 8.4±10.3 u/week p<0.001). Accordingly, females reported less often COPD (41% vs. 57%; p<0.001) and liver disease (11% vs. 20% p<0.001). However, they had a higher prevalence of bronchiectasis (24% vs. 13% p<0.001). Despite better lung function (FEV1%pred. 69.2±28.5 vs. 58.2±27.0 p<0.001) females reported a similar symptom burden (CAT 13.4±9.5 vs. 12.5±8.9 p=ns) and exacerbation frequency ≥1 in the last year (30% vs. 26% p=ns) compared to males. In multivariate analyses, female gender was an independent risk factor for exacerbations OR 1.57 p=0.001 in addition to smoking history, COPD, asthma and bronchiectasis and was also identified as risk factor for symptom burden (CAT≥10) OR 1.43 p=0.013 besides age, BMI, COPD and smoking history. Conclusion: Men had higher rates of COPD and liver disease, women were more likely to have bronchiectasis. Women's higher symptom burden and exacerbation frequency suggest they may need tailored treatment approaches.
respiratory system